Genetic characterisation of canine and equine papillomaviruses and papillomatoses by Lange, C E
 
 
 
Genetic Characterisation of Canine 
and Equine Papillomaviruses and 
Papillomatoses 
 
 
 
Dissertation 
 
Zur Erlangung der Doktorwürde 
 
(Dr. sc. nat.) 
 
Vorgelegt der Mathematisch-naturwissenschaftlichen Fakultät 
 
der Universität Zürich  
 
von 
 
 
Christian Erwin Lange 
 
aus  
 
Deutschland 
 
 
 
 
Promotionskomitee: 
 
Prof. Dr. Urs F. Greber (Vorsitz) 
 
Prof. Dr. Claude Favrot (Leitung der Dissertation) 
 
Prof. Dr. Cornel Fraefel 
 
Prof. Dr. Jens P. Teifke 
 
Prof. Dr. Tierry Hennet 
 
 
Zürich, 2011 
 2 
 
 
 
Table of contents 
 
 
 
Summary           3 
 
Zusammenfassung          4 
 
Introduction           6 
 
Part I – Canine papillomaviruses and papillomatoses in dogs    26 
 
 Canine inverted papillomas associated with DNA of four different   27 
papillomaviruses 
 
Three novel canine papillomaviruses support taxonomic clade formation  33 
 
The clinically healthy skin of dogs is a potential reservoir for canine   43 
papillomaviruses 
 
Generation of canine keratinocyte cell lines harbouring canine   50 
papillomavirus DNA over more than 100 passages 
 
Part II – Equine papillomaviruses and papillomatoses in horses   67 
 
 Identification of two novel equine papillomavirus sequences suggests   68 
three genera in one cluster 
 
 In situ hybridization supports papillomavirus etiology in equine penile   75 
papillomas 
 
Conclusions and Outlook         87 
 
Publications at a glance          93 
 
Curriculum vitae          95 
 
Acknowledgements          96 
 3 
 
 
 
Summary 
 
Papillomaviruses can infect epithelia of humans and animals, resulting in most cases in 
asymptomatic infections. However many benign and several malignant disorders were shown 
to result from papillomavirus infections. Many different papillomaviruses have been 
described, most of them infecting humans. Animals have their own papillomaviruses but 
relatively few animal papillomaviruses are characterized or known at all. Even in common 
domestic animals, like the dog and the horse only one papillomavirus each had been studied 
in some detail in the past. This study was consequently initiated to shed more light onto the 
papillomavirus situation in these two species and to establish viable tools for this purpose. We 
were able to identify novel canine papillomaviruses (CPVs) associated with distinct clinical 
conditions. The DNA genomes from some of these viruses were cloned and sequenced.  We 
found, that histologically distinct types of inverted papillomas seem to be associated with the 
presence of DNA belonging to different CPVs. Sequence analyses of newly cloned CPV 
genomes revealed that these genomes belonged to the papillomavirus genera Lambda, Tau 
and Chi. This phylogenetic characterization was supported by analysis of other features, such 
as genome organization and genome size. Some clinical-pathological characteristics were also 
reflected in this categorization, above all the finding that all CPVs inducing pigmented 
plaques belonged to the Chi papillomavirus genus. Based on a careful evaluation of PCR 
assays it was possible to show that viral DNA could be detected in the clinically healthy tissue 
from oral mucosa and interdigital skin of dogs. As a first step towards developing a tool for 
future research on the mechanisms of virus cell interaction, we have in addition generated 
keratinocyte cell lines harboring and transcribing the DNA of CPV1, CPV3 or CPV5 
respectively. We also conducted a related project on horse papillomaviruses. In the horse 
papillomatoses are a well known problem and have already been described in ancient times. 
Curiously, the best known papillomavirus affecting horses so far is a bovine papillomavirus, 
BPV1, involved in the equine sarcoid. In this project, we identified equine papillomaviruses 
(EcPVs) in two other occasionally observed disorders, namely penile papillomas and aural 
plaques. We established PCR and in situ hybridisations and showed that samples of penile 
papillomas from the histological archive were positive for either of two described variants of 
EcPV2. Viral DNA was located in the nuclei of koilocytes, cells typical for active viral 
infection in the skin. This test might help in the molecular classification of equine 
papillomatoses.  
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Zusammenfassung 
 
Papillomaviren können Epithelien wie vornehmlich Haut und Schleimhäute von Mensch und 
Tier infizieren, was meist zu asymptomatischen Infektionen führt. Papillomaviren stehen 
nichts desto trotz auch mit vielen gutartigen sowie einigen bösartigen Tumoren in 
Verbindung. Obgleich die meisten derzeit bekannten Papillomaviren den Menschen betreffen, 
haben auch Tiere ihre eigenen Papillomaviren. Tierpapillomaviren kennt man allerdings 
bisher nur bei einer Hand voll Spezies und auch jeweils nur wenige Vertreter. Über die 
Biologie der Papillomaviren bei Tieren ist in den meisten Fällen kaum etwas bekannt. Selbst 
bei weit verbreiteten Haustierspezies wie dem Hund und dem Pferd wurde jeweils gerade ein 
Papillomavirus etwas genauer studiert. Folglich zielte unsere Studie darauf ab, die 
Papillomavirus Situation in diesen beiden Spezies etwas genauer zu beleuchten und in diesem 
Zusammenhang brauchbare Techniken für die weitere Erforschung zu etablieren. Wir konnten 
neue mit typischen Veränderungen assoziierte Hundepapillomaviren (CPVs) identifizieren 
und einige von diesen wurden kloniert und sequenziert. Wir konnten zeigen, dass bestimmte 
histologisch unterschiedliche Arten von invertierten Papillomen auch mit unterschiedlichen 
Arten von CPV DNA in Verbindung zu stehen scheinen. Die Analyse der Gensequenzen von 
neu entdeckten und klonierten CPVs liess eine Zuordnung zu den Papillomavirus Genera 
Lambda, Tau und Chi zu. Diese phylogenetisch basierte Zuordnung wurde durch andere 
genetische Charakteristika wie Genomorganisation oder Grösse unterstrichen. Auch einige 
typischerweise zu beobachtende klinisch-pathologische Charakteristika einzelner 
Krankheitsbilder wurden von dieser Zuordnung wiedergespiegelt, in erster Linie die 
Versammlung aller mit flachen pigmentierten Warzen (pigmentierten Plaques) assoziierten 
CPVs im Chi Genus. Basierend auf einer gründlichen PCR Evaluation konnte des Weiteren 
gezeigt werden, dass virale DNA auch auf klinisch gesunder Haut der Maulschleimhaut und 
in Zwischenzehenspalt des Hundes vorkommt. Um ein Model für zukünftige Studien für 
Virus-Zell Interaktionen zu haben, wurden Keratinozyten-Zelllinien etabliert, die die DNA 
der CPVs 1, 3 oder 5 tragen und diese auch übersetzen. Auch beim Pferd sind Papillomatosen 
bereits seit der Antike bekannt. Das am besten beschriebene Papillomavirus in diesem 
Zusammenhang ist jedoch eines des Rindes (BPV1), welches beim Equinen Sarcoid eine 
Rolle spielt. Wir konnten weitere Pferdepapillomaviren (EcPVs) in zwei weiteren Arten von 
gelegentlich auftretenden Veränderungen identifizieren, nämlich bei Penispapillomen und  
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flächig flachen Ohrwarzen (auralen Plaques). PCR und in situ Hybridisierung wurden 
etabliert, um mehr Aufschluss darüber zu erlangen, welche Rolle die Papillomaviren in 
solchen Penisläsionen spielen. Diese Methoden wurden dann angewendet um entsprechende 
Proben aus dem histologischen Archiv zu testen. Alle getesteten Proben enthielten DNA einer 
von zwei EcPV2 Varianten. Die DNA war in den Kernen der Koilozyten lokalisiert, die 
typisch für virale Infektionen sind.  
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Introduction 
 
Viruses 
Viral diseases can be traced back through the whole human history, but viruses themselves 
were only discovered in the late 19th century. The identification of the tobacco mosaic virus as 
the first plant and foot and mouth disease virus as the first animal virus mark the beginning of 
virus research (Mayer, 1886; Iwanowsky, 1892; Loeffler, 1897; Loeffler, 1898). However the 
viral nature of micro filterable sub microscopic pathogens was for several decades all that was 
known. The development of electron microscopy and molecular biological techniques during 
the 20th century contributed decisively to the understanding of virus structure and biology 
(Bernal, 1941; Black, 1963). The knowledge about viruses and viral diseases has 
consequently increased vastly to the present day. Although there are enormous differences 
among different kinds of viruses they share some common features: Each virus is build of at 
least the viral capsid (protein) and the genetic information (RNA or DNA) contained therein. 
Based on this genetic information and the mechanisms used to replicate it, viruses can be 
allocated to seven categories, in particular double stranded DNA viruses (I), single stranded 
DNA viruses (II), double stranded RNA viruses (III), positive strand single strand RNA 
viruses (IV), negative strand single strand RNA viruses (V), single strand RNA viruses with 
reverse transcriptase activity (VI) and double stranded DNA viruses with reverse transcriptase 
activity (VII) (Baltimore, 1971; Temin, 1972). In the overall virus taxonomy properties like 
morphology and sequence homology are used as additional criteria to define for example 
order and family. The criteria below that level may however differ significantly. While in 
some virus families serotype designations are used other viruses like papillomaviruses are 
primarily classified according to their nucleic acid sequence (Bernard, 2010). 
Viruses differ from other pathogens like eukaryotic parasites, funguses and bacteria not only 
in terms of size. A main difference is that all viruses are obligate parasites of cells. They 
dependent entirely on the host cell to provide all resources for viral reproduction, and also to a 
variable degree on the cellular machinery. Viruses may therefore be described as being “at the 
edge of life”, as they fulfil most but not all current criteria of a life form (Rybicki, 1990). Due 
to their relative simplicity several theories about the origin of viruses have been formulated 
including the hypothesis, that viruses are the closest relatives to the earliest life forms and 
contrary views regarding them as degenerate parasites or genes that became independent. 
Consequently their role in evolution has been and is controversially discussed and there are 
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various arguments pro and contra an inclusion of viruses in the tree of life (Podolsky, 1996; 
Forterre, 2002; Moreira, 2009; Ludmir, 2009; Forterre, 2010). 
 
Viruses and cancer 
Although viruses may have often be perceived as pathogens directly inducing obvious 
diseases, that it is not the only role they play. While apparent viral induced maladies like foot 
and mouth disease or small pox caught the attention of virologist from the beginning on, other 
more complex or less obvious effects of viral infections moved into the focus more recently 
(Loeffler, 1898; Fenner, 1988; zur Hausen, 2002). Not long after the existence of viruses 
infecting plants and animals had been demonstrated, the hypothesis that viruses could be 
involved in cancer development was already formulated. It was based on the finding of 
transmittable tumours in chickens and confirmed later (Ellermann, 1908; Rous, 1911; Bryan, 
1955). Today the etiology of a series of malignant neoplasias is known, in which viruses are 
essentially involved including feline leukemia, the hepatocellular carcinoma, Burkitt’s 
lymphoma and cervix carcinomas. Although it is believed that viruses play a role in the 
development of at least 12% of all cancers in humans, malignant transformation is not a 
necessary part of virus life cycle but an accidental side effect (zur Hausen, 2001; Parkin, 
2006; de Martel, 2009). Consequently the mechanisms involved in this process differ among 
the viruses and even virus types. Integration of viral DNA that can turn cellular proto-
oncogenes into oncogenes as in case of retroviruses is a common feature, but not universal for 
tumour viruses. The interaction of oncogenic viral proteins with the cellular machinery is very 
common in case of DNA tumour viruses. 
Although the infection is a mandatory element in virus induced oncogenesis, other factors are 
usually involved. One such factor could be an acquired immunodeficiency like HIV-AIDS 
that can promote the development of virus induced tumours like Kaposi’s sarcoma, Burkitt’s 
lymphoma or cervical cancer (International Collaboration on HIV and Cancer, 2000). 
However the immune reaction may as well contribute to tumourous developments as is 
discussed in case of hepatitis B (Sanyal, 2010). Another factor could be a genetic 
predisposition as demonstrated in the case of epidermodysplasia verruciformis (Jablonska, 
1972).  
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Double stranded DNA viruses 
Viruses carrying their genetic information in form of double stranded DNA are manifold and 
to date two orders, nineteen Families and five unassigned genera belong to this group 
(Fauquet, 2005). However, virus classification is still an ongoing process as the ongoing 
research is constantly unveiling new genotypes, serotypes and entirely novel viruses. Among 
the group of double stranded DNA viruses are members with large genomes like the members 
of the herpesvirales or the mimiviridae which have the largest yet discovered viral genome 
and encode many viral genes. Nevertheless, there are also double stranded DNA viruses with 
genomes well below ten thousand basepairs like papillomaviruses or polyomaviruses coding 
for only few genes. Because these two both have circular genomes and due to similarities in 
capsid structure they were initially grouped together in the family Papovaviridae (Belnap, 
1996). As genome size and organisation were found to differ and no significant sequence 
homologies could be identified, this categorisation was abandoned and the taxonomic families 
Polyomaviridae and Papillomaviridae were established. However, some similarity exists in 
the encoded helicase motives and recently a virus with papillomavirus and polyomavirus 
features was discovered (de Villiers, 2004; Woolford, 2007). 
 
Papillomaviruses 
Papillomaviruses consist of a non-enveloped icosahaedral capsid and their doublestranded 
DNA genome contained therein. The capsid is comprised of the viral proteins L1 and L2 and 
has a diameter of 50-55 nm (Figure 1) (Crawford, 1963; Baker, 1991; Belnap, 1996). The 
genomes of papillomaviruses are circular and approximately eight thousand basepairs in 
length (Figure 2). Unlike in polyomaviruses all genetic information is coded on the same 
strand of the papillomavirus genome (Chen, 1982). Four open reading frames can easily be 
identified on this coding strand in all papillomaviruses, namely the early ones E1 and E2 as 
well as the late ones L1 and L2. Most papillomaviruses also contain the two additional early 
open reading frames E6 and E7 and in some papillomavirus genera an E5 open reading frame 
is also characteristic (de Villiers, 2004). There is also an E4 open reading frame located 
within E2, however the according start codon is located upstream of it. Other early open 
reading frames can be identified in a few papillomavirus types, where they often are replacing 
position and possibly functions of E6 and/or E7 (Tachezy, 2002; Terai, 2002). 
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A large non coding region downstream of the L1 open reading frame (usually between L1 and 
E6) harbours the origin of replication of the papillomaviruses; several have a second non 
coding region between E2 and L2 whose relevancy is unknown (Chen, 1982, Delius, 1994; 
Schulz, 2009a). 
 
 
Figure 1          
Canine papillomaviruses isolated from a pigmented lesion. Negative contrast electron 
microscopy. 
 
 
 
 
Image: E. M. Schraner, UZH 
 
 10 
 
 
 
Papillomavirus classification 
The current classification of papillomaviruses within the Papillomaviridae family is based on 
nucleotide sequence identities in one of the papillomavirus genes, namely L1. The L1 open 
reading frame was chosen because it is the most conserved among the known 
papillomaviruses. This choice was also strongly supported by the observation, that 
phylogenetic relationships based on whole genomes or even parts of it differ only marginally 
from phylogenetic relationships based on L1 (de Villiers, 2004). 
However, when criteria for genera (<60% identities), species (>60% identities), types (>70% 
identities), subtypes (>90% identities) and variants (>98% identities) were defined, complete 
sequences of only one hundred eighteen papillomaviruses were available, most of them being 
human papillomaviruses (de Villiers, 2004). Thus the usefulness of this single gene based 
classification in the context of papillomavirus evolution is controversially debated, as are the 
mechanisms of papillomavirus evolution. There is evidence that virus-host co-evolution is a 
driving force in papillomavirus diversification based mainly on the analysis of human 
papillomaviruses but also on the analysis of papillomaviruses of other closely related host 
species (Tachezy, 2002; Bernard, 2006; Rector, 2007). In contrast it could be demonstrated, 
that different genes have different evolutionary histories when papillomaviruses of more 
distant host species are taken into account (Gottschling, 2007; Stevens, 2008; Schulz, 2009a, 
b). Thus papillomavirus evolution is probably a complex matter involving different 
mechanisms. 
At the moment the family of papillomaviridae contains 29 defined papillomavirus genera 
(Bernard, 2010), but the number of distinct papillomavirus types is growing constantly with 
already more than 200 being sequenced in their entity. The currently rapid accumulation of 
novel viral sequences constitutes a challenge for papillomavirus virus nomenclature. Thus just 
recently new names for additional genera were proposed and the nomenclature of several 
papillomavirus types was suggested to be changed in order to avoid misunderstandings and 
for more stringency (Bernard, 2010). 
 
Papillomavirus genes 
The inability to culture papillomaviruses has been one of the main obstacles in papillomavirus 
research and although various model systems have been established, there is still no suitable 
way for culturing papillomaviruses (Meyers, 1994; Conway, 2009; Liebertz, 2010). However, 
molecular cloning made it possible to analyse the genomes in detail and to establish various 
model systems for papillomavirus infections. It became possible to produce pseudovirions  
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consisting of one (L1) or both structural proteins as well as to study the interactions of viral 
and cellular proteins, thus linking papillomavirus gene products to pathogenesis (Kirnbauer, 
1993; Hagensee, 1994). The nomenclature of papillomavirus genes is mainly based on the 
localisation of open reading frames and on sequence homology (Figure 2). While there are 
only few open reading frames that can easily be identified in papillomavirus genomes, 
excessive splicing has been shown to give rise to a variety of gene products fulfilling different 
functions in the viral lifecycle (Baker, 1987; Hummel, 1992; Stubenrauch, 1999). However, 
even with only few papillomaviruses studied in particular detail it has become clear, that not 
all these nominally similar genes give rise to proteins with identical functions. Especially as 
the papillomavirus gene products seem to interact with a great number of cellular proteins. It 
consequently appears that papillomaviruses developed different mechanisms throughout 
evolution, which may explain some of the differences in papillomavirus mediated diseases 
(Roberts, 2002; Howley, 2007). 
 
Figure 2 
Schematic display of a papillomavirus genome; Equine papillomavirus type 1 
 
Early genes 
The gene products of E1 and E2 fulfil certain well defined functions in the papillomavirus life 
cycle and are therefore believed to be rather conserved in terms of sequence and function 
among the different papillomavirus types. E1 gene products are primarily involved in  
Image: Vector NTI Software 
 
 12 
 
 
 
replication, as the main product is a helicase that also has the ability to recruit replication 
initiation factors to the papillomavirus genome (Conger, 1999; Loo, 2004). E1 usually forms a 
complex with E2 that has accessory functions in the replication initiation (Masterson, 1998). 
Besides enhancer functions for the replication E2 products play a primary role in 
transcriptional control, being able to function as a transactivator as well as a repressor of the 
viral genes. Another role of E2 is the distribution of the papillomavirus genomes during cell 
division. In case of papillomavirus integration the E2 open reading frame is often destroyed or 
entirely lost, thus leading consequently to a loss of its functions, resulting for example in 
uncontrolled E6 and E7 expression (Zur Hausen, 2002). 
The roles of the other early gene products are not as well conserved among the 
papillomaviruses and so are their nucleotide sequences. E6 and E7 open reading frames can 
be identified in most, E5 in certain clades of papillomaviruses as in those from the genus 
alpha (de Villiers, 2004). Each of these gene products has been found to have many different 
cellular targets, and research in this field is still ongoing (Zur Hausen, 2001; Regan, 2008). 
Due to their oncogenic potential the roles of E5, E6 and E7 have been studied in great detail 
in case of the human papillomavirus 16 (HPV16), consequently these mechanisms are often 
referred to. The most striking finding in HPV16 E5 is that it interacts with the epidermal 
growth factor receptor, thereby inducing accelerated cell growth (Crusius, 2000). With respect 
to HPV16 E6 it is well established, that its products are able to interact with the ubiquitin 
ligase E6AP which leads to the ubiquitination and degradation of the tumour suppressor p53. 
E6 products also interact with the proapoptotic protein Bak leading to its degradation 
(Jackson, 2000; Horner, 2004). The best studied mechanism regarding HPV16 E7 is its 
interaction with regulatory protein pRB, mediating its proteolytic degradation and in the 
consequence leading to E2F mediated transcriptional activation of cell cycle genes (Cheng, 
1995). 
 
Late genes 
Two genes are defined as late genes in the papillomavirus genome, as they are expressed in 
late stages of a papillomavirus infection (Baker, 1987). However, as this is not experimentally 
determined for all papillomaviruses, these late genes are identified according to their position 
and due to similarities with late genes of other papillomaviruses. The two L genes give rise to 
the two proteins L1 and L2, both having structural functions. The L1 protein is the main 
component of the viral capsid. It forms pentamers that assemble to the 72 pentamer 
icosahedral structure of the papillomavirus capsid. This assembly takes place even in the  
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absence of the second structural protein L2, and this spontaneous assembly of viral capsids 
has been used for several applications including diagnostic and prophylactic ones (Segre, 
1955; Kirnbauer, 1993; Hagensee, 1994; Kirnbauer, 1994; Harro, 2001). As L1 is much more 
abundant in the viral particle, it is also known a major capsid protein, while L2 is counted as 
minor capsid protein. However L2 is also a mandatory part of the infectious viral particle, as 
it plays a major role in uncoating and intracellular transport (Kämper, 2006). The protein 
derived from the E4 open reading frame is despite its designation rather a late one too. Its 
open reading frame is entirely incorporated in E2 and the E4 product is subject to several 
posttranscriptional modifications. Consequently various E4 protein species can be identified 
in case of each virus type. The E4 products are involved in the packaging of the viral 
particles, interacting with the cytoskeleton and with epidermal differentiation (Doorbar, 1991; 
Bryan, 2000; Roberts, 2002). 
 
Virus life cycle 
The target cells of papillomavirus infections are with only few exceptions epithelial cells, 
specifically epidermal keratinocytes and cells of the mucous membranes. In these tissues, 
especially in the squamous epithelium, cells undergoing cell division are only present in the 
basal cell layer. Only these cells are suitable targets for papillomaviruses to establish 
persisting infections. Several layers of differentiated and differentiating cells however protect 
these undifferentiated keratinocytes from the hazards of the environment. It is consequently 
believed that papillomaviruses require sites of small injuries to be able get in contact with 
those basal cells (Oriel, 1971; Dürst, 1991; zur Hausen 1996). 
One of the receptors papillomaviruses attach to is α6 integrin, but it has been shown, that this 
receptor is not mandatory for all papillomaviruses (Evander, 1997; Sibbet, 2000). The entry 
mechanism thereafter is clathrin-dependent receptor-mediated endocytosis, at least for most 
studied papillomaviruses (Day, 2003). Once in the endosome, the L1 of the viral capsid is 
lost, whereas the L2 mediates the escape into the cytoplasm and later the nuclear localisation 
of the viral genome (Day, 2004; Kämper, 2006). 
After infection there is an initial phase of replication, resulting in a cell containing few to a 
few hundred copies of the papillomavirus genome. In case of most studied papillomaviruses it 
is located in episomal form in the nucleus of the infected cell. Some papillomaviruses 
however, like the human ones HPV16 and HPV18 often integrate into the host genome. This 
integration is usually associated with a loss of function of the E2 open reading frame and 
consequently with malignant transformation (Von Knebel, 1988; Desaintes, 1997). 
 14 
 
 
 
After the early events in the papillomavirus life cycle each genome is copied about once per 
cell cycle in synchrony with the host genome. This type of maintenance replication is retained 
in the undifferentiated basal cells (Gilbert, 1987). The differentiation process in the offspring 
of the infected basal cells however triggers various viral mechanisms like higher E1 and E2 
expression. That leads to production of more copies of the genome as well as late gene 
expression resulting in the production and packaging of viral particles in the apical cells of the 
tissue (Bedell, 1991; Ozbun, 1998). As papillomaviruses are not lytic viruses, the release of 
infective viruses is probably due to the normal death of cells in apical layers of epithelia 
(Lehr, 2003). 
 
Papillomaviruses - pathogens in humans 
Although asymptomatic infections are common, various benign and several malignant human 
skin disorders have been linked to papillomavirus infections (Jablonska, 1997). Cutaneous 
papillomas like common warts are frequent, usually benign and transient, but in some 
disorders like epidermodysplasia verruciformis malignancy occurs in rare cases (Jablonska, 
1972; Majewski, 1997). Among the variety of known papillomavirus associated cutaneous 
and mucosal disorders cervical cancer is the best studied and due to its consequences probably 
the most relevant one. In more than 99% of the cases this disease can be linked to human 
papillomavirus (HPV) infections (Walboomers, 1999). It has been shown, that HPV infection 
is mandatory but not sufficient for tumorigenesis in these cases. Several genetic and 
environmental risk factors have been identified, that may play a role in the development of 
malignancy which is usually a process of many years. Still, although cofactors play an 
important role, the type of papillomavirus seems most relevant, as some are found much more 
frequent in malignant lesions than others. This led to the clinical distinction between high risk 
and low risk HPVs (Lorincz et al., 1992 and Bosch et al., 1995). High risk HPVs usually have 
a potential to integrate into the host genome, which is one of the typical mechanisms involved 
in papillomavirus associated tumorigenesis. The disease complex and its main viral players 
HPV16 and HPV18 are now best understood ones, even though there are still many open 
questions (zur Hausen, 1999; zur Hausen, 2000). The intensive research has lead to the 
development of two prophylactic vaccines against the most abundant HPV types in the past 
years and future research may enable even better and cheaper vaccines as well as more 
reliable diagnostic options (zur Hausen, 2002; Gissmann, 2007). 
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Papillomaviruses in animals 
Animals as well as humans are hosts of papillomaviruses and develop benign and malignant 
lesions as well (Figure 3). Some of these diseases such as warts had actually been known 
since ancient times, and consequently the first papillomaviruses studied in detail were those 
inducing neoplasias in cattle, cottontail rabbit and domestic rabbit (Shope, 1933; Parsons, 
1943; Black, 1963). After intensive early approaches to uncover the details of papillomavirus 
biology, which included detailed studies involving the bovine type BPV1 as a model, animal 
papillomaviruses moved out of the focus of the research community (Chen, 1982; Baker, 
1987). Due to the species specificity of most papillomaviruses animals were nevertheless 
expected to have their own specific papillomaviruses. Still, while about 150 HPV types have 
yet been entirely and many more partially sequenced papillomaviruses infecting animal 
species are probably vastly underrepresented. Although to date more than 70 animal 
papillomaviruses have been entirely sequenced (including those mentioned in this work), only 
few, a single one or often no papillomaviruses per mammalian species are known (Bernard, 
2010; pages 92-93). Only in the past decade, as modern molecular biology methods became 
more sophisticated and easily available paired with a rising interest in health issues of pets 
brought again life into this field. It was hypothesised, that in analogy to what is now known 
about HPVs animals may have various different papillomavirus related disorders, maybe 
similar to human counterparts (Antonsson, 2002). However, there are still many open 
questions, not only about the roles of papillomaviruses in animal disease in particular, but also 
about the evolution and evolutional mechanisms of papillomaviruses in general (Garcia-
Vallve, 2005; Gottschling, 2007; Rector, 2007). Even the entire range of hosts is far from 
being well defined, the fragmentary data nevertheless suggests, that all tetrapods could 
potentially have their own papillomaviruses (Bernard, 2010). 
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Figure 2 
Canine oral papillomatosis in a young dog. 
 
Aims of the study 
While various skin disorder in humans could be linked to a variety of specific HPVs in past 
decades, papillomatous lesions in animals where often simplistically blamed on “the 
papillomavirus” as for example canine papillomavirus (CPV1) in dogs. It had been suggested 
that there might be more than one (Nicholls, 1999), and more recent findings supported that 
hypothesis (Tanabe, 2000; Narama, 2005; Goldschmidt, 2006; Tobler, 2006; Yuan, 2007). 
Our studies were consequently aimed to determine whether specific skin disorders may 
indeed be linked to CPVs other than CPV1. Very closely connected is also the question 
whether the hypothesis that each animal might harbour an own set of papillomaviruses is true 
or not, as there was evidence for this in cattle (Campo, 1984; Hatama, 2008; Hatama 2009). 
To determine the relevance of putative papillomavirus findings it was furthermore of interest 
whether CPV DNA like HPV DNA may be present on the skin in the absence of lesions as 
well (Antonsson, 2000; Antonsson, 2003). To learn more about cellular mechanisms of 
papillomavirus infections in general and in dogs in particular, establishing a cell culture based 
system to study the effects of CPVs on their natural host cells was also aspired. 
 
Image: C. E. Lange, UZH 
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A second focus was on equine papillomaviruses (EcPVs). Horses are frequently affected by 
papillomavirus associated lesions; however, most of the knowledge about papillomaviruses in 
horses is connected to the bovine papillomaviruses BPV1 and BPV2 which induce the equine 
sarcoid (Scott, 2003; Nasir, 2008). We intended to figure out whether other papillomatous 
equine disorders may be linked to papillomavirus infection and if so to which 
papillomaviruses (Scott, 2003). 
 
Thesis structure 
This thesis is divided into two parts. The first part focuses on different aspects of canine 
papillomaviruses and papillomatoses and the second part on equine papillomaviruses.  
Four manuscripts, three of them presented in their published layout and one in a publication 
ready format, make up the first part. The first manuscript deals with the question whether 
certain disorders of dogs are associated with papillomaviruses, and if so with which ones. 
Based partially on the results from the first article the second manuscript deals with the 
genetic and phylogenetic characterisation of the seven canine papillomaviruses. While these 
two address questions of association, the third article focuses on screening methods and the 
counter question whether papillomavirus DNA can also be found on clinically healthy skin. 
The part about canine papillomaviruses concludes with a manuscript describing the generation 
of a cell culture model for the study of papillomavirus cell interactions. 
Two manuscripts, one already published and one submitted, are combined to form the second 
part which is devoted to equine papillomaviruses. The first manuscript introduces two novel 
equine papillomaviruses and places them into a clinical and phylogenetic context. The second 
focuses on one of the virus associated disorders and seeks to support the hypothesis of 
causality using different methods. 
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Part I – Canine papillomaviruses and papillomatoses in dogs 
 
Although the existence and the transmissive character of  papillomatoses in dogs has been 
known for a long time the knowledge about the involved viruses and the molecular 
mechanisms remained rather fragmentary. The best studied canine papillomavirus (CPV) is 
the one inducing the canine oral papillomatosis CPV1 (prior known as COPV). After CPVs 2 
and 3 had been discovered a few years ago we intended to determine whether the three CPVs 
may be sufficient to explain the different pathologies in dogs and to develop a culture model. 
We identified four additional CPVs associated with various pathologies; three of those were 
cloned and sequenced. We found, that histologically different types of inverted papillomas 
seem to be associated with the DNA of different CPVs (Canine inverted papillomas 
associated with DNA of four different papillomaviruses, pages 15-20). The analysis of the 
genomic sequences of the newly cloned viruses revealed that they could be allocated to the 
same three genera as CPVs 1, 2 and 3, namely papillomavirus genera Lambda, Tau and Chi. 
This phylogenetic characterization was supported by other genomic features like for example 
genome organization and genome size. Also some shared clinical-pathological characteristics 
were reflected in this categorization, most evident is that the Chi genus harbours only CPV 
associated with pigmented plaques or else all CPVs inducing pigmented plaques are Chi 
papillomaviruses (Three novel canine papillomaviruses support taxonomic clade formation, 
pages 21-30). Eight broad range PCRs with published primer combinations were thoroughly 
evaluated for future research and diagnostic purposes in dogs. Based on these results the 
question whether dogs like humans may harbour papillomaviral DNA on their clinically 
health skin was addressed. We detected CPV DNA in many samples of oral mucosa and 
interdigital skin, thus confirming the hypothesis (The clinically healthy skin of dogs is a 
potential reservoir for canine papillomaviruses, pages 31-37). To have a tool for future 
research on the mechanisms of virus cell interaction the generation of a cell culture model was 
approached. Canine keratinocyte cell lines were successfully transduced using the amplicon 
system to harbour and translate the DNA of CPV1, CPV3 or CPV5 respectively (Generation 
of canine keratinocyte cell lines stably harbouring canine papillomavirus DNA, pages 38-52). 
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  Table S1 
Characteristic features on nucleotide and amino acid level 
 
A 
 
 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
GC content 
 
42% 46% 51% 53% 50% 40% 46% 
 
 
B 
 
Predicted nt-feature 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
E2 binding site 
(ACC-N6-GGT) 
203; 321 331; 434; 
3747; 5259 
116; 179;  
285; 325;  
416; 475;  
498; 1274; 
4501; 5460 
57; 124;  
314; 404;  
463; 487; 
4506; 5575 
107; 170;  
317; 406;  
465; 490; 
1270; 2217; 
4518; 4762;  
5624; 7088 
88; 252;  
320; 390;  
845; 2482; 
2616; 6233; 
6508 
156; 173; 
 327; 356;  
431; 2736; 
5070 
Dyad symmetry repeats * 
(TTGTTGTTAACAACAA) 
281 393 454 442 444 275 99; 390;  
667; 4532; 
7507 
 Poly adenylation sites 
(AATAAA) 
24; 5524; 
5637; 7055; 
7123 
3; 72; 310; 
5469; 6069; 
7621 
4850; 7800 4786; 4790; 
7741 
2499; 7809 17; 4036; 
4250; 5276; 
7136; 8179; 
8242 
59; 4512; 
4986; 6692; 
7271; 7954 
SP1 binding sites 
(GGCGGG) 
3824 5508 462 552; 3458; 
4889; 5116 
555 3455 1861; 5198 
NF1 binding sites 
(CGGAA) 
911; 825; 
1686; 2640; 
2771; 3098 
401; 969; 
2392; 3155; 
3914; 6775 
204; 230; 
301; 522; 
2408; 3408; 
3633 
209; 250;  
279; 510; 
1640; 2260; 
4572; 5840; 
6260 
195; 215;  
255; 360;  
514; 2407; 
2729; 3239; 
3629; 4166; 
4722; 5712 
155; 3949; 
4583; 6464; 
6535 
398; 3464; 
5264; 6626 
Tata signals 
(TATAAA or 
TATA(A/T)A(A/T)) 
354; 1882; 
2155; 6599; 
7255; 8133 
192; 449; 
3518; 4547; 
4555; 4642 
174 429;  
6088 
2722 348; 1897; 
2170; 4437; 
4484; 4627; 
4838; 7450 
38; 448; 
1732; 3203; 
3512 
 
* Modified in all cases but CPV3 and CPV4 
Underlined starting positions are part of the putative origin of replication 
 
C 
 
Predicted aa-feature 
 
COPV CPV2 CPV3 CPV4 CPV5 CPV6 CPV7 
ATP-dependent helicase motifs 
in E1 † (GPPNTGKS) 
426aa/ 
2356nt 
437aa/ 
2494nt  
456aa/ 
2642nt  
457aa/ 
2632nt 
457aa/ 
2641nt  
431aa/ 
2365nt 
434aa/ 
2485nt  
metal-binding motifs in E6 ‡ 
(CX2CX29CX2C) 
33aa/ 460nt 
106aa/679nt 
25aa/ 568nt 
98aa/ 787nt 
25aa/ 642nt 
98aa/ 861nt 
25aa/ 632nt 
98aa/ 851nt 
25aa/ 635nt 
98aa/ 854nt 
25aa/ 460nt 
98aa/679nt 
25aa/ 560nt 
98aa/ 779nt 
metal-binding motifs in E7 ‡ § 
(CX2CX29CX2C) 
52aa/ 948nt 50aa/ 
1035nt 
59aa/ 
1144nt 
53aa/ 
1131nt 
54aa/ 
1140nt 
52aa/ 945nt 50aa/ 
1053nt 
pRb binding domain in E7 
(LXCXE) 
22aa/ 858nt - 28aa/ 
1051nt 
23aa/ 
1041nt 
23aa/ 
1047nt 
24aa/ 861nt - 
 
† Modified (GPPDTGKS) in all cases but COPV, CPV4 and CPV6 
‡ Modified (CX2CX28CX2C) in case of COPV and CPV6 
§ Modified (CX2CX30CX2C) in case of CPV2 and CPV7 
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Figure S1: Box plot analysis comparing the distribution of genome sizes 
among the HPV genera Alpha (HPVs 2, 3, 6, 7, 10, 11, 13, 16, 18, 26, 27, 28, 
29, 30, 31, 32, 33, 34, 35, 39, 40, 42, 43, 44, 45, 52, 53, 54, 55, 56, 57, 58, 59, 
61, 62, 66, 67, 68, 69, 70, 71, 72, 73, 74, 77, 81, 82, 83, 84, 90, 94, 97, 102, 
106), Beta (HPVs 5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 37, 38, 
47, 49, 75, 76, 80, 92, 93, 96, 98, 99, 100, 104, 105, 107, 109, 110, 111, 113) 
and Gamma (HPVs 4, 48, 50, 65, 88, 95, 101, 103, 108, 112). The differences 
among the genera proved significant (P < 0.05) in Bonferroni test (PRISM, 
GraphPad Software). 
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S3: PCR screening for PV DNA with canPVf/FAP64 primers on healthy skin. dogGAPDH 
PCR was included as internal control. Numbers of individual dogs are divided into the sixteen 
combinations of positive and negative PCR results for GAPDH and PV DNA of oral and 
interdigital samples.  
 
 PV DNA  
oral pos / paw pos 
PV DNA 
oral pos / paw neg 
PV DNA  
oral neg / paw pos 
PV DNA  
oral neg / paw neg 
GAPDH 
oral pos / paw pos 14 14 10 39 
GAPDH 
oral pos / paw neg 0 9 2 7 
GAPDH 
oral neg / paw pos 0 0 0 0 
GAPDH 
oral neg / paw neg 0 0 0 0 
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Abstract 
 
Papillomaviruses are small DNA viruses that can be linked to asymptomatic infections, but 
also to various benign and several malignant disorders of the skin and mucous membranes. 
Many such viruses and associated diseases have been described in humans, but little is known 
about the similar conditions in animals such as the dog. Consequently our aim was to 
establish a cell culture model, in order to have a tool for future studies on the pathogenesis of 
papillomavirus induced conditions. For this purpose DNA of the canine papillomaviruses 
CPV1, CPV3 and CPV5 was introduced into canine keratinocytes using the Herpesvirus 
Amplicon system. Successfully transduced cells were enriched based on GFP expression 
using fluorescence activated cell sorting. The cells were subsequently monitored for GFP 
expression, for the presence of viral DNA and for DNA transcription. Cells could be found 
positive for GFP, DNA and RNA over more than one hundred passages post transduction, 
indicating that the cell lines stably harbour papillomavirus DNA. In conclusion keratinocyte 
cell lines containing and transcribing the DNA of canine Papillomaviruses were generated. 
These cell lines may serve as a model for future studies on pathogenic mechanisms of 
papillomaviruses. 
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Introduction 
 
Papillomaviruses (PVs) are DNA viruses with a double stranded circular genome of about 
8kbp in size contained in a nonenveloped icosahaedral capsid of about 50nm. PVs primarily 
infect epithelial cells and can cause subclinical infections but also benign proliferations which 
may progress into malignant tumours (Chen et al., 1982; Baker et al., 1991; Jablonska et al., 
1997; zur Hausen, 1999).  The most intensively studied PV associated disease is the cervix 
carcinoma, which can be induced by several PV types, most frequently by the human PVs 
(HPVs) 16 and 18. These two viruses and their effects on the organism have consequently 
been studied in great detail, as the cervix carcinoma is one of the most abundant cancers in 
women worldwide (zur Hausen, 1999). Not all of the currently more than 150 known HPV 
types have been intensely studied as PVs can not easily be propagated in cell culture and less 
is for example known about the PVs of the Beta genus. PVs belonging to this genus are 
involved in various diseases of the skin, which may even be more common than cervix 
tumours. However PV associated skin diseases rarely progress to malignancy and 
mechanisms in these cases are only partially understood (Sterling, 2005). 
PVs and associated diseases have also been identified in animals, and it can be assumed that 
each species harbours its own set of PVs as they are predominantly species-specific 
pathogens. 
PV associated lesions in dogs have been described in the past (Nagata 1995, Nicholls and 
Stanley, 1999). Although the association of distinct PVs with each of the observed conditions 
was suspected years ago, support for this hypothesis was found only recently (Zaugg et al., 
2005; Tobler et al., 2006; Yuan et al., 2007,). To date entire genomic sequences of seven 
canine papillomaviruses (CPVs) have been determined (Lange et al., 2009). These CPVs were 
grouped into the three genera Lambda, Tau and Chi based on the nucleotide sequences of 
their L1 open reading frame (ORF) (Bernard et al., 2010). The associated lesions range from 
transient warts over persistent benign pigmented or unpigmented tumours, to in situ and 
invasive squamous cell carcinomas (SCCs). 
Although the course of infection has repeatedly been observed and described in case of CPV1 
(Nicholls and Stanley, 1999), and various data support the role of CPV2 in the development 
of tumours (Yuan et al., 2006; Goldschmidt et al., 2006, Lange et al., 2010), little is known 
about the underlying mechanisms in any CPV associated pathology.  
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To address the question what effects CPV DNA has on their target cells, a model could be of 
great value. To generate such a model for CPV infection we choose a canine keratinocyte cell 
line (Kolly C. 2005). DNA of three CPVs was selected to be introduced in the cells, one from 
the Lambda genus (CPV1) and two from the Chi genus (CPV3, CPV5). The Herpes Amplicon 
system was used to transduce keratinocytes and GFP signal served as a tool for sorting and 
assessment of transduction (Fraefel et al., 1996). 
 
Materials and Methods 
 
Cloning 
For the purpose of rolling circle amplification (RCA) (Rector et al., 2004), a TempliPhi 
Amplification kit (General Electrics Biosciences) was used. The protocol supplied by the 
manufacturer was used, with slight modifications: 1 µl of dNTPs (10 mM) was added and the 
reaction time was prolonged to 16 h at 30°C. One microliter of DNA extract served as 
template. In order to amplify the PV genomes of CPV1, CPV3 and CPV5 without their L1 
and L2 ORFs according primers adding a SbfI restriction site were designed (Table 1). A 
Phusion (Finnzymes) polymerase (0.5µl) was used adding 0.5µl of each primer (10µM), 5µl 
buffer HF (Finnzymes), 0.5µl dNTPs (10mM), 3.75µl Betaine (5M), 1.25µl DMSO and 12µl 
sterile water to 1µl of template (RCA product 1:100). Conditions for the PCRs were chosen as 
follows: 94°C for 5 min followed by 35 cycles of 94°C for 1 min, 55°C for 1 min and 72°C 
for 4 min. A final elongation step, 10 min. at 72°C concluded the program. PCR products 
were subcloned into HSV-1 amplicon plasmids containing a GFP gene under a 4/5 promoter 
and an ampicillin resistance gene (D’Antuono et al., 2010). A new restriction site was 
introduced into the HSV-1 amplicon plasmid using a palindromic oligonucleotide that 
destroys the NdeI site and introduces a SbfI site (Table 1). Thus the PV DNA remains under 
its own and GFP independent under the 4/5 promoter. E. coli DH10B cells were transformed 
to multiply the construct, growing them in LB medium containing 100µM ampicillin. DNA 
was harvested using a DNA maxi kit (Qiagen). Helper virus-free stocks of the vectors were 
prepared (Fraefel et al., 1996; Saeki, et al., 1998; Saeki et al., 2001). The HSV-1 genome was 
provided in trans by a bacterial artificial chromosome (BAC) containing the HSV-1 genome 
with deletions in the DNA cleavage/packaging signals and the essential ICP27 gene 
(fHSVpacICP27) (D’Antuono et al., 2010). 
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Cell culture 
To observe the effects of CPVs on their primary target cells a canine keratinocyte cell culture 
deriving from a Beagle was chosen (Kolly C. 2005). The cells were cultured in CnT-09 
medium (Cell`n`Tec) in 25cm3 cell culture flasks (TPP). Cells were split 1:20 every 3-4 days. 
Transduced cells were split 1:5 or 1:10 over the first 33 passages, afterwards 1:10 
continuously. 
For RAFT culture growth Milicell 12mm wells (Millipore) were inserted into a 24 well plate. 
106 cells were seeded per well and cultured in CnT-09 medium for three days before cells 
were exposed to air (5% CO2). Medium was subsequently supplemented exclusively from 
underneath and changed twice a week. RAFT cultures were harvested two weeks after being 
emerged, formalin fixed and paraffin embedded for further processing. 
 
Transduction 
To introduce the PV specific DNA into the canine keratinocytes 105 cells were seeded per 
well of a 24 well plate (TPP) in CnT-09 medium one day pre transduction. A volume of 200µl 
of unconcentrated Amplicon preparation with titers of around 5 x105 TU/ml was applied on 
the cells for 90 minutes and washed away afterwards. 
 
FACS 
The transduced cells were sorted for GFP using a FACSAria II (BD) machine. First sorting 
took place twelve days post transduction (enrichment), successive sortings 23 and 53 days 
post transduction (purity). Gating was orientated on untransduced keratinocytes. 
 
PCR (DNA/RNA) 
To extract DNA from the cultures 106 cells of each cell line were taken and processed using 
the QIAamp DNA extraction kit (QIAGEN) according to the manufacturer’s instructions for 
cultured cells. For RNA extraction a kit (Machery & Nagel) was used according to the 
manufacturer’s instructions. Additionally the RNA extract was incubated with DNase I 
(Roche) for 30 minutes. For reverse transcription of RNA a kit (Promega) was used according 
to the manufacturers’ instructions. 
Primers were designed to amplify DNA of the main early ORFs of CPV1, CPV3 and CPV5, 
namely E6, E7, E1 and E2 by PCR (Table 1). RedTaq polymerase ready reaction mix (Sigma) 
was used according to the manufacturer’s recommendations.  
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PanAAV primers were constructed based on the sequences of seven human AAVs 
(NC_002077, NC_001401, NC_001729, NC_001829, NC_006152, NC_006260, 
NC_006261) as well as the AAV of the cow (NC_005889), two avian AAVs (NC_006263, 
AY629582) and the goose parvovirus (NC_001701) (Table 1). RedTaq polymerase ready 
reaction mix (Sigma) was used according to the manufacturer’s recommendations. Conditions 
for the PCRs were chosen as follows: 94°C for 5 min followed by 39 cycles of 94°C for 30 
sec, 60°C for 1 min and 72°C for 30 sec. Wildtype human AAV2 DNA served as positive 
control. 
 
Results 
 
In order to establish a model system for CPV infection, genomic DNA lacking the structural 
genes of CPV1, CPV3 and CPV5 was amplified and cloned into herpesvirus amplicon 
plasmids. The plasmids were packaged into herpesvirus particles and used to transduce canine 
keratinocytes (Kolly C. 2005). To rule out that the cell line used in the experiment contains 
any PV DNA, PCR and RCA were applied to amplify potential PV DNA. No evidence of PV 
DNA was found prior to transduction. Additionally, the cell line was tested for the presence of 
DNA of a putative Adeno associated virus; no such DNA was amplified from the cell line 
(data not shown). 
To determine the completeness of the constructs used, the CPV inserts were sequenced. The 
CPV1 insert was found to differ in from the published sequence in two positions located in 
the second non coding region, namely nucleotides 4617 and 4626. In case of CPV3 nucleotide 
680 of the E1 ORF turned out to be an adenine instead of a guanine, thus substituting the non-
conserved E1 amino acid 227 Serin by Asparagin. The CPV5 insert was found to be identical 
with the published sequence.  
Four days post transduction a GFP signal could be observed in 10-15% of the cells under the 
UV microscope. After three FACS steps the ratio of GFP positive cells was above 70% in 
each of the cell lines transduced with constructs containing viral DNA (Figure 1). In the cells 
transduced with the control amplicon no GFP signal was present after the first sorting, 
consequently no further sorting was conducted. The amount of cells being GFP positive upon 
microscopic observation decreased gradually over the following passages as well as the 
intensity of the GFP signal. After 68 passages still several CPV3 transduced cells expressing 
GFP could be identified, more than 10% in case of the CPV1 transduced cells and even more 
than 50% in case of CPV5 transduced cells. However, upon FACS assessment after 105  
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passages more than 90% of CPV5, more than 80% of CPV1 and about 1% of CPV3 
transduced cell lines were found to be GFP positive (Figure 2). 
To verify that the transduced cell lines contain the DNA of the main ORFs E6, E7, E1 and E2 
and of the GFP gene according primers were constructed and PCR was performed (Table 1). 
DNA of all these genes was amplified in case of the CPV1, CPV3 and CPV5 transduced cell 
lines (Figure 3). The same primers were used for RT PCR to demonstrate transcription of 
viral genes. In case of all three viral constructs cDNA of the E6, E7, E1 and E2 ORF was 
amplified after DNAase treatment and reverse transcription. No DNA was amplified in the 
controls without reverse transcriptase (Figure 3). The cultures were repeatedly tested for DNA 
and RNA up to 105 passages post transduction and were consistently positive in the PCR.  
The presence of the entire inserts within the cell lines was confirmed after 105 passages using 
overlapping PCRs in case of all three CPV containing cell lines. 
 
To test whether the presence of the introduced viral DNA has any effects on the growth and 
differentiation of the keratinocytes, untransduced and transduced cell lines were grown in 
RAFT culture 43 passages post transduction. No morphological differences between 
transduced and untransduced cell lines were detectable (data not shown). The application of 
specific markers for differentiation, multiplication and apoptosis namely Lamin A, Loricrin, 
Ki-67 and P53 did not reveal statistically significant differences in the amount of marker- 
tagged cells. No cells positive for GFP signal or GFP immunostaining were seen in any 
preparation. 
 
Discussion 
 
While CPVs have been shown to be associated with several skin disorders little is known 
about the underlying mechanisms. Consequently the aim of this project was to generate a tool 
that could help revealing effects of PV DNA on their natural host cells.  
Three viruses were chosen for this study: CPV1 as it is the best studied and possibly most 
abundant CPV, CPV3 as a causal relation with cancer has been suggested and CPV5 as it is 
the closes known relative to CPV3. As PVs cannot simply be propagated in cell culture many 
strategies to study their effects on cells have been applied (Meyers and Laimins, 1994; 
Conway and Meyers, 2009; Liebertz et al., 2010). We considered and tested several 
transfection strategies, including chemical transfection with several different agents and 
electroporation. The transfection rates were at the best around 10-20% (data not shown).  
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However, as the survival rate of GFP positive cells after sorting was very poor we decided to 
use the Amplicon system as this is a very gentle method of introducing DNA of interest into 
target cells. The system also uses GFP as marker gene for successfully transduced cells. This 
enables relatively easy tracking and also sorting for GFP expressing cells. It is unlikely that 
the empty vector would replicate alone, because although it does contain an HSV origin of 
replication (ORI) it lacks the gene for the according HSV DNA polymerase. This was most 
probably the reason for the loss of GFP signal in the cells transduced with the empty plasmid. 
The plasmids containing the PV DNA on the contrary carry the PV regulatory region, which 
harbours the PV ORI. As PVs utilize the host DNA polymerase in association with the 
geneproducts of E1 and E2 all necessary machinery should be available in the accordingly 
transduced cells. It remains unclear, in which form the heterologous DNA exists in the cells. 
It was introduced in linear, concatemeric form, but might have formed circular plasmid DNA 
or could eventually have integrated into the host genome. The according experiments where 
however inconclusive. No circular DNA could be amplified via RCA, what might be due to a 
copy number below the detection level of RCA (Lange et al., 2011). The completeness of the 
insert was confirmed by PCR. Consequently homogeneous cell lines with integrated PV 
genomes are unlikely, as integration is usually associated with the destruction of a PV ORF, 
like E2 in case of HPV18 (zur Hausen, 2002; Howley and Lowy, 2007). 
In the cells transduced with the plasmids containing the DNA of CPV1, CPV3 and CPV5 the 
GFP signal could be used for sorting, resulting in cell lines with a high proportion of GFP 
positive cells. Although the signal intensity decreased over time, the cell lines harbouring 
CPV1 and CPV5 were GFP positive in FACS to a high proportion even after more than 100 
passages. However, even with restrictive sorting the proportion of fluorescent cells never 
reached 100%. This might be due to cells, that were sorted incorrectly, cells that may have 
lost the DNA during cell division or possibly due to the inability to express GFP at certain 
stages. 
As it was observed that the cell lines expressed GFP up to 105 passages post transduction, it 
can be concluded, that these cells stably harbour the DNA.  
As GFP has been merely a tool for FACS and for optical assessment, the main focus is the PV 
DNA that was brought into the keratinocytes. To check for PV DNA specific primers for the 
four main ORFs had been made for each of the three viruses. DNA was extracted from cells at 
different time points and PCR was continuously positive up to 105 passages post transduction. 
DNA of GFP and canine p53 coding sequences was also amplified from these cells. This 
supports the assumption, that the cell lines expressing GFP also harbour the DNA of CPV1, 
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CPV3 and CPV5 respectively. The transcription was also assed in parallel based on the same 
genes and primers. As RNA could be detected as well, and as the DNA is successfully 
contained in the cell lines over many passages, it can be concluded, that the viral genes are 
active in the three cell lines.  
 
 
As the papillomavirus lifecycle is closely linked to the lifecycle of keratinocytes, the 
replication and gene expression of PVs depends on the stage of the infected cells (Oriel, 1971; 
zur Hausen, 1996). As monolayers may only represent the basal layer of keratinocytes a three 
dimensional model with the different stages of the keratinocyte lifecycle might trigger viral 
programs that are not active in continuously replicating cells. We applied the RAFT culture 
model for this purpose and used some markers for cellular processes. As no differences could 
be seen in comparison to untransduced cells, several possible explanations may exist. As the 
development of papillomaviral disorders often seems to be a process with a long 
asymptomatic phase, the experiment might have been performed in a phase of infection that is 
too early. It is also possible, that the time the cells where allowed growing as a RAFT culture 
was to short. Besides these it might also be considered, that the virus DNA alone is not 
sufficient to induce changes in keratinocytes. More experiments in these directions are 
therefore warranted. 
 
In conclusion, we can resume, that we successfully transduced keratinocyte cell lines with the 
DNA of CPV1, CPV3 and CPV5 respectively. The DNA of the three viruses is stably 
contained in the cell lines over more than 100 passages and the main genes age transcribed. 
Thus we have generated cell lines that can be very useful in addressing questions about the 
effects of CPV DNA on their natural target cells, to improve the understanding about PV 
pathology in general and in dogs in particular. 
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Figure legends 
 
 
Figure 1 
Canine keratinocytes 7 passages after transduction. Cell lines transduced with CPV1 (A, B), 
CPV3 (C, D) and CPV5 (E, F) in translight and under UV for GFP detection. 10x Objective 
of a Zeiss Axiovert S1000 microscope. 
 
Figure 2 
FACS assessment of canine keratinocytes. Non transduced keratinocytes served as control to 
set gating parameters. CPV1, CPV3 and CPV5 transduced keratinocytes 105 passages after 
transduction. FL1-H indicates GFP. 
 
Figure 3 
PCR on keratinocyte DNA and RNA extracts. PCR assays for E1, E2, E6 and E7 DNA of 
CPV1 (first row), CPV3 (second row) and CPV5 (third row) 5 passages after transduction. 
PCR performed on RNA extract with reverse transcription (RT+), RNA extract without 
reverse transcription (RT-) and DNA extract (DNA). M indicating 1 kb marker with bands of 
about 500, 400, 350, 300 and 200 nucleotides displayed. 
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Table 1 Primerlist 
 
Primer Name Sequence Binding & size 
COPV_no_L_SbfI_f AAC CCT GCA GGT GTG TCA TTG ATT 
ACT TGT 
8360 - 8389 
COPV_no_L_SbfI_r CCC TGC AGG TGC GTA AGC GAG GGA 
TGT TTT 
5289 - 5318 
CPV3_no_L_SbfI_f CTT CAC CTG CAG GAC GCT CTG TTA 
AAA GG 
7216 - 7244 
CPV3_no_L_SbfI_r TAC CCT GCA GGA CCA TGA CAA GTC 
AAC 
4208 - 4234 
CPV5_no_L_SbfI_f CGC CCT GCA GGT CTA CTT CTA AAT 
CTA CAC GA 
7229 - 7260 
CPV5_no_L_SbfI_r GCG CCT GCA GGA TGA CAG GTC AAC 
AGG TGA CAA 
4223 - 4255 
Nde-Sbf Oligo TAT GAC TGC CTG CAG GCA GTC A  
COPV_E6_f TTT GCT TGA TCT GTC GCT T 198 
COPV_E6_r GTT CTT TGT CCG CCT CAC T 478       
281 
COPV_E7_f CGC AAC CCT TTT GGA TAT T 569 
COPV_E7_r CTA GCC GCC ATG GTC AA 848       
280 
COPV_E1_f AGA CTG AGG ATG GTG GTT G 866 
COPV_E1_r GGC GTT AAG CTA ATG CTT G 1139      
274 
COPV_E2_f GCA CTG GTC ATT GCT CAG A 2665 
COPV_E2_r CCC AGG TGT CAA ACT CAT C 3011      
347 
CPV5_E1_f AGG GAG GAC AAT AGG CAG G 951 
CPV5_E1_r TAA ATG GCC TGG TCA ACT CC 1362      
412 
CPV5_E6_f ATG GAG CCT TGC AGG TCT TA 48 
CPV5_E6_r GCC CTC TGA CCT TTT TGA AT 412        
365 
CPV5_E7_f TTG GGA AAG ACG CTA CTT TGA 459 
CPV5_E7_r AGA CCG GAC AGC AGA ATG AT 722        
264 
CPV5_E2_f CTG TCA GAT CAG GTC CAG CA 2653 
CPV5_E2_r TCC GTG AAA TAC ACG TGG TG 2999      
347 
CPV3_E7_f TTG GGA AAG ACG CTA CTT TGA 444 
CPV3_E7_r CTC CAT GGT CAA AGC GGT AG 737        
294 
CPV3_E6_f GAG TGT CTC TGT GCG CGA TA 68 
CPV3_E6_r CAC CGC CCT CTC ACT TTT T 404        
337 
CPV3_E1_f AGG GAG GAC AAT AGG CAG GT 939 
CPV3_E1_r GGT TAG ACG CTC GCA TTA GC 1272      
334 
CPV3_E2_f TGC AGG ACA CCA GCT ATG AG 2840 
CPV3_E2_r TGT GGT GCT GGT GAC AGA TT 3171       
332 
panAAV f GTN AAC TGG ACY AAY GAA AAC TTT 
CC 
 
panAAV r KKG GAA TCG CAA TGC CAA T  
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Part II – Equine papillomaviruses and papillomatoses in horses 
 
Papillomatoses in the horse are a well known problem and have already been described in 
ancient times. However, the best known papillomaviruses affecting horses are bovine ones 
(BPV1 and BPV2) involved in the equine sarcoid. This BPV1 associated semimalignant 
tumors mark the only confirmed pathology linked to papillomaviruses crossing a species 
barrier. Only one equine papillomavirus (EcPV) that is typically associated with transient 
benign tumours of the young horse was yet identified. Previous primarily clinical and 
pathological findings however suggested that there could be at least three different 
papillomavirus induced disorders, potentially involving different papillomaviruses. 
We identified EcPVs in two other occasionally observed disorders, namely penile papillomas 
(EcPV2) and equine aural plaques (EcPV3). Based on the genomic sequences of these viruses 
a phylogenetic allocation of the two novel viral sequences was possible (Identification of two 
novel equine papillomavirus sequences suggests three genera in one cluster, pages 54-60). 
We established PCR and in situ hybridisation to verify whether the papillomavirus involved in 
the penile lesions (which are presented more often than aural plaques) and used them to test 
seven paraffin embedded samples from cases of the past years. All these samples were 
positive for either of two described variants of EcPV2. Viral DNA was located in the nuclei of 
koilocytes, cells typical for active viral infection in the skin (In Situ Hybridization Supports 
Papillomavirus Etiology in Equine Penile Papillomas page 61-72). 
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Abstract 
Equine penile papillomas, in situ carcinomas, and invasive carcinomas are suspected to belong to a 
continuum of papillomavirus-induced diseases and to represent the equine counterpart of human 
bowenoid papulosis. They present clinically as grayish small plaques to flat warts developing 
subsequently into more hyperplastic or, alternatively, ulcerated lesions. Histologically, lesions range 
from hyperplasia of the epidermis with sparse koilocytes to in situ or invasive squamous cell 
carcinomas. 
In order to test the hypothesis that these lesions are papillomavirus-induced, seven samples of horses 
with characteristic clinical and histological findings of penile papillomatosis and/or squamous cell 
carcinomas were collected and tested by PCR. The respective primers were designed to amplify DNA 
of the recently discovered equine papillomavirus EcPV2. The tested samples were all found positive. 
To further support the findings and to locate the papillomavirus DNA an in situ hybridization for the 
detection of EcPV2 DNA was established. The samples tested by this technique were found to harbor 
a vast amount of papillomavirus nucleic acid concentrated in the nucleus of the koilocytes. These 
findings taken together support the theory of papillomaviruses inducing the described penile lesions in 
horses. 
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Papillomaviruses (PVs) are small double stranded DNA viruses that play an important role in the 
development of various benign and malignant neoplastic disorders of the skin and mucous 
membranes in humans and animals.5 In horses, lesions being associated with bovine PVs, namely the 
equine sarcoid, have been well described.1,7 This phenomenon however, the interspecies transmission 
of PVs, is regarded as rather exceptional. Three actual equine PVs (EcPVs) have been identified in 
lesions that had previously been suggested to be potentially PV associated.4,6,8 Those are the so 
called classical equine viral papillomas which are typically found in young horses, genital papillomas, 
and equine aural plaques.6 One of the viruses, namely EcPV2, has not only been identified in genital 
papillomas and carcinomas from which it had been isolated, but also in ocular squamous cell 
carcinomas.9 Additionally, EcPV2 DNA was identified in swaps of clinically unaffected skin.9 
Equine penile papillomas, in situ carcinomas, and invasive carcinomas are suspected to represent the 
equine counterpart of human bowenoid papulosis. They present clinically as greyish small plaques to 
flat warts developing subsequently into more hyperplastic or, alternatively, ulcerated lesions. 
Histologically, lesions range from hyperplasia of the epidermis with sparse koilocytes to in situ or 
invasive squamous cell carcinomas. 
The finding of PV DNA on unaffected skin rises the question of what role the virus plays in the PV 
positive lesions. To address this question we evaluated two PCRs and a specific in situ hybridization 
(ISH) and applied the techniques on samples of penile papilloma and penile SCC.  
 
Materials and Methods 
Samples 
Samples were obtained from the Institute of Veterinary Pathology and were chosen according to the 
original clinical and pathological diagnosis. 
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In situ hybridization 
To generate an ISH probe, forward (5`- GAG CTG TGC AGT GTC ACG TT -3`) and reverse (5`- TCT 
CCT GGA CAA GCC ACT CT -3`) primer were designed based on the L1 gene sequence of the 
published sequence of EcPV2. The DIG labeled probe was generated using the PCR DIG Probe 
Synthesis Kit (Roche) according to the manufacturer’s protocol. Following PCR conditions were 
applied: 95°C for 3 min followed by 35 cycles of 95°C for 30 sec, 60°C for 30 sec and 72°C for 30 sec. 
Labeled PCR products were extracted from an agarose gel using a MinElute gel extraction kit 
(Qiagen).  
A DIG labelled probe targeting the GFP gene was generated in an analogous way employing following 
forward (5`-AGG ACG ACG GCA ACT ACA AG-3`) and reverse (5`-CTG GGT GCT CAG GTA GTG 
GT-3`) primers. The same PCR conditions were used, a pHSV-eGFP amplicon vector served as 
template.2 This probe served as negative control throughout the hybridization experiments.  
Tissue sections (3-4µm) were obtained using a microtome (HYRAX M55, Zeiss) and samples were 
placed onto positively charged slides (Thermo Scientific). Sections were dewaxed (3 x 5 min in Xylol, 
followed by 5 min in Isopropanol, 5 min in 96% Ethanol, 5 min in 100% Ethanol and finally 5 minutes in 
sterile water). 
To inactivate endogenous phosphatases, the slides were washed twice for 5 min with PBS before and 
after incubation in 0.2 M HCl for 8 min. The tissue was permeabilized by treatment with 10µg/ml 
proteinase K in 10 mM Tris-HCl (pH 7.5) for 10 min followed by two washing steps in PBS for 10 min 
and equilibration in 2 x SSC for 2 min. Denaturation of the DNA within tissue sections was performed 
by adding 120 µl of denaturation buffer (70% formamide, 2 x SSC), covering the sections with a 
coverslip and incubation of the slide for 90 sec at 80°C. Thereafter, the slides were immediately 
submerged in 70%, 90% and 100% of ice cold ethanol for 3 min each and then air dried.  
Thirty ng of probe were denatured in 50 µl hybridization solution (50 % deionized formamide, 2 x SSC, 
1 x Denhardt`s solution, 10 % dextran sulfate, 0.5 mg/ml yeast tRNA, 0.5 mg/ml hydrolyzed salmon 
sperm DNA), for 10 min at 80°C before they were applied to the slides.  
Slides were cover slipped and hybridized at 55°C for 20 h in a humid chamber.  
After hybridisation slides were washed with 2 x SSC for 10 min followed by 2 x 50% formamide, 1 x 
SSC and one with 0.2% SSC each one for 20 min at hybridization temperature. For color detection, 
the slides were washed 3 x 5 min in TNT buffer (0.1 M Tris-HCl, pH 7.5; 0.15 M NaCl, 0.05% Tween 
20), incubated for 30 min in TNB (0.1 M Tris-HCl, pH 7.5; 0.15 M NaCl, 0.5% blocking reagent  
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(Roche)) followed by  300 µl per slide antiDIG-AP Fap antibody (1:500 Roche) in TNB at RT for one 
hour in a humid chamber. After 3 washing steps with TNT for 5 min, followed by a 2 min equilibration 
step in  detection buffer (100 mM NaCl, 100 mM Tris-HCl, pH 9.5; 50 mM MgCl2), the slides were 
incubated with substrate solution (337 µg/ml NBT (Roche), 175 µg/ml BCIP (Roche), 5 mM 
Levamisole in detection buffer) for 2 hours. Slides were counterstained for 4 min with nuclear fast red 
and finally rinsed in water for 5 min. Stained slides were fixed with Kaiser’s glycerol gelatin. If not 
indicated otherwise, all steps were performed at room temperature. 
 
PCR evaluation 
Two primer combinations were evaluated for PCR. One was the primer combination EcPV2probe f / 
EcPV2probe r which amplifies a 294nt stretch of the L1 open reading frame of EcPV2 and served also 
to generate the ISH probe. The second one was the primer combination EcPV2d f (5`- CAG ACT TGT 
CTG GGC TCT CC -3`) and EcPV2d r (5`- TCC CGC CTA GCA TAG AAG AA -3`), which had been 
designed to amplify a 474nt stretch of the L1 open reading frame of EcPV2. To determine the 
approximate detection levels of the PCRs serial dilutions were made from 109 down to 101 molecules 
of an entire genomic clone of EcPV2. For that purpose the DNA concentration of the plasmid stock 
solution was measured using a Spectrophotometer (ND-1000, Thermo Scientific). According the 
plasmid-size the amount of molecules per microliter was calculated. RedTaq ready reaction mix 
(Sigma) was used and conditions were chosen for both PCRs as follows: 94°C for 3 min followed by 
39 cycles of 94°C for 30 sec, 50°C for 30 sec and 72°C for 30 sec.  
 
DNA amplification and analysis 
To test the samples total DNA of fixed tissue samples was isolated using a DNeasy extraction kit 
(Qiagen) according to the manufacturer's recommendations for paraffin embedded tissues. 
EcPV2probe f / EcPV2probe r PCR was used to test the samples. Electrophoresis in a 1% agarose gel 
containing ethidium bromide was used to detect the amplified fragments. PCR products were 
extracted from the gel using QIAEX II DNA extraction kit (Qiagen). 
The nucleotide sequences of the PCR products were determined (Microsynth) by cycle sequencing 
using an ABI 377 sequencer (Applied Biosystems). The sequences of each isolate were aligned and a 
consensus sequence of 169 nucleotides was generated for each one. The sequences were compared  
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with the NCBI database (BLAST X) and were all aligned with the according L1 stretches of the two 
available sequences of EcPV2. 
 
Results 
Histology and ISH 
Seven male horses (six geldings, one unknown) with depigmented plaques, nodules and/or 
ulcerations of the penis were included in the study. Their ages ranged from 8 to 23 years; three 
patients were Islandic horses (cases Nos. 4, 6 and 7) (Fig. 1), one Noriker horse (case No. 5), one 
Westphalian warmblood (case No. 1), one cob (case No. 2), and one horse of unknown breed (case 
No. 3). 
 
Tissue biopsies were taken for histological examination, processed routinely and Hematoxylin & Eosin 
stained. In all seven cases hyperplastic areas were present, displaying regular differentiation of the 
epidermis with large irregular rete ridges formation, and containing scattered degenerated cells with 
homogeneous pale cytoplasm as well as scattered koilocytes (Figs. 2 & 3). 
In some cases, namely cases Nos. 3, 5 and 6, there were also areas with progression to in situ 
squamous cell carcinoma characterized by irregular differentiation, inhomogeneous nuclear sizes in 
the different levels of the epidermis and in some cases mitoses above the basal cell layer. In other 
ones, namely cases Nos. 1, 2, 4 and 7, a diagnosis of squamous cell carcinoma was made based on 
the finding of invasion of the underlying dermis and numerous neoplastic cells in these areas 
koilocytes were less frequent in the overlying epidermis (Fig. 4). However, in the latter cases in situ 
squamous cell carcinomas could also be found in other locations. One case of each of the groups was 
chosen for ISH analysis, using the EcPV2 as well as the GFP control probe. 
Upon ISH a strong signal was evident in many of the koilocytes, while no signal was present when a 
control probe was used (Figs. 5-6). 
 
DNA amplification and analysis 
In order to use PCR for PV detection, two primer combinations amplifying DNA from the L1 open 
reading frame of EcPV2 were evaluated. Both combinations performed equally well when tested on 
serial dilutions of EcPV2-plasmid DNA (Fig. 7). The detection level in both cases was around 100 
copies of template. However, as fixed samples were used in this study, the primer combination with  
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the smaller product was chosen. DNA could be amplified from all seven samples (Fig. 7). The 
sequencing of the products confirmed the DNA to belong to EcPV2. While the sequences obtained 
from cases Nos. 1, 2, 3 and 5 were identical, those of the cases Nos. 4, 6 and 7 differed in two 
positions (6921 and 7002 relative to EcPV2-HM461973). Aligning the seven sequences with the 
according stretches of the two EcPV2 sequences revealed that the sequences of cases Nos. 1, 2, 3 
and 5  were identical with EcPV2-NC_012123 while the sequences of cases Nos. 4, 6 and 7 were 
identical with EcPV2-HM461973 (Fig. 8). In cases were more than one sample of a horse was tested 
the same variant was consistently detected. 
 
Discussion 
Equine penile papillomas, in situ carcinomas, and invasive carcinomas are a common disease and 
may require harsh treatment (amputation) when diagnosed in late stages. The involvement of PVs had 
been suggested and a putatively involved PV had been identified. However, although good evidence 
exists that EcPV2 is causally involved in the mentioned pathologies, the finding of DNA in unaffected 
skin makes further evidence desirable.6,9 The histological findings of the cases included here support 
the previous hypothesis, as characteristics of a viral infection like koilocytes are present. To confirm 
and determine the viral DNA in fixed samples, PCR is the most feasible method. Therefore, we 
decided to design primers binding in the L1 ORF as this is the most conserved region in the 
papillomavirus genome, and it is also used for classification.3 The evaluation of the two primer 
combinations revealed almost equal sensitivity tested on plasmidic DNA as template. We chose the 
primer combination amplifying the shorter stretch of DNA, as the samples we had for testing were 
extracted from formalin fixed, paraffin embedded tissues. Since formalin is known to induce DNA 
damage, the chances of successfully amplifying DNA from such a sample is higher if the PCR product 
is small. Additional evidence from own experiments encouraged that choice (data not shown). The 
chosen PCR amplified DNA from all tested samples. Sequencing of the bands confirmed the DNA to 
be identical with EcPV2. Interestingly, the short stretches of sequences of some of the samples 
corresponded exactly to one of the known EcPV2 variant while the others exactly to the other EcPV2 
variant. The sample size of this study is of course too small to draw definite conclusions from this, but 
both can obviously be found in the penile lesions. 
ISH was established to determine whether the EcPV2 DNA, which had been amplified from the 
samples, is indeed located within the cells, indicting a causal involvement, or if it is just present on the  
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skin in the role of a bystander. For this purpose, an EcPV2 specific and an unrelated probe of about 
equal size were generated and applied in the same way. Signal was only present in the sample when 
EcPV2 probe was applied. As DNA was detected within the koilocytes, it can be ruled out that the 
DNA is only present superficially on the skin. As koilocytes are regarded as typical indicators for a PV 
infection, finding PV DNA within their nucleus supports the hypothesis that EcPV2 is involved in the 
development of the respective lesions. 
In conclusion, a PCR suitable for EcPV2 detection in fixed samples has been evaluated and 
successfully applied. DNA of two EcPV2 variants was found in seven samples of equine penile 
papilloma, in situ and/or invasive carcinoma. The association of viral DNA with koilocytes has been 
shown by ISH. These findings taken together support a causal context of equine penile papilloma, in 
situ carcinoma, and invasive carcinoma with EcPV2. 
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Figure Legends 
Figure 1 
Penis; horse, case No. 7. Amputated distal part of a penis with neoplasias. 
 
Figure 2 
Penis; horse, case No. 6. Hyperplastic epidermis containing scattered degenerated cells with 
homogeneous pale cytoplasm and koilocytes with vacuolated cytoplasm. 10x objective, HE stain. 
 
Figure 3 
Penis; horse, case No. 1. Numerous koilocytes within hyperplastic epidermis. 40x objective, HE stain. 
 
Figure 4 
Penis; horse, case No. 1. Infiltratively growing squamous cell carcinoma, 4x objective, HE stain. 
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Figure 5 
Penis; horse, case No. 1. Epidermal hyperplasia with numerous koilocytes. 10x objective, in situ 
hybridization of DIG labeled DNA probe complementary to GFP, counterstain with nuclear fast red. 
 
Figure 6 
Penis; horse, case No. 1. Epidermal hyperplasia with numerous koilocytes. 10x objective, in situ 
hybridization of DIG labeled DNA probe complementary to EcPV2, counterstain with nuclear fast red. 
 
Figure 7 
PCR evaluation of the primer combinations EcPV2d (A) and EcPV2probe (B) indicating the target 
molecules in the test solution. PCR of the seven equine samples using the primer combination 
EcPV2probe (C). M stands for 1kb marker. 
 
Figure 8 
Partial electropherograms from the PCR products of the seven samples indicating the two differing 
bases. Positions relative to the sequence of EcPV2-HM461973. 
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Conclusions and Outlook 
 
Much has been found out about papillomaviruses, the associated diseases and the biology of 
the viruses affecting humans. Far less is known about the situation in most animal species and 
about the phylogeny of the Papillomaviridae family as such. Consequently there is still a need 
to learn more about papillomaviruses, for reasons of animal welfare and conservation but also 
for a better understanding of mechanism of virus biology and evolution. 
  
As described, several experiments were made in order to expand our knowledge about 
papillomas and papillomaviruses in dogs and horses. In dogs we identified four distinct 
conditions of endophytic papillomas that were associated with the DNA of different 
papillomavirus types (pages 26-31). Two of these types, namely CPV1 (COPV) and CPV2 
were previously described (Delius, 1994; Yuan, 2007), the other two were not. As the 
association of certain types of papillomaviruses with certain lesions has been described in 
humans, the findings indicate some parallels (Arndt, 1994; Beck, 1995). While CPV2 has 
previously been reported to be involved in the same ones as described in our case there 
remains a desire to assess whether the other papillomavirus will consistently been found in the 
reported lesions in the future (Goldschmidt, 2006). Nevertheless, as such parallels have been 
anticipated this supports the validity of our approach to identify putative papillomavirus 
associated skin disorders in animals by inferences from known human ones. Besides from 
testing whether the associations suggested will consistently be found it may as well be worth 
looking for the subtypes and variants involved in the inverted papillomas. It is currently a 
field of intense research, what influence variations in the early genes E6 and E7 have on the 
pathologies associated with HPVs (Xi, 2006). Similarly it could be of interest to test whether 
there are for example differences between CPV1 isolates found in oral papillomas and those 
CPV1 isolates found in skin lesions like inverted papillomas. 
 
In order to characterize the agents involved in papillomavirus associated disorders on the level 
of their genetics and phylogenetics, one of the above mentioned and two other novel canine 
papillomavirus genomes were cloned, and analysed (pages 32-41). A consequent comparison 
of all canine papillomaviruses supported not just previous suggestions about dogs being 
affected by their own set of papillomaviruses but indicated also that these viruses, similar to 
what is known about human and to a lesser extend about bovine papillomaviruses, cluster 
together in only a few phylogenetic genera (de Villiers, 2004). Based on the data, though  
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limited, it may be inferred, that some predictions about the course of infection are possible 
based on viral genetics in combination with clinical findings. Detailed clinical assessment of 
papillomatoses and sequencing of further canine papillomaviruses can consequently be very 
helpful to test the scheme we indicated and to expand it. In the future it may help to predict 
the course of infection if it may turn out, that certain types or clades of CPVs are typically 
associated with transient and others with persistent disorders. In this context it will for 
example be interesting if putatively novel Chi papillomaviruses will be associated with 
pigmented plaques and vice versa. 
 
Although it is well established that papillomaviruses are responsible for several benign and 
malignant disorders, their DNA has also been found on the clinically healthy skin of humans 
and several other species (Antonsson, 2000; Antonsson, 2003). To be able to put our previous 
findings of certain papillomaviruses being associated with certain disorders into a broader 
context and to be able to test dogs with well established methods for papillomavirus DNA 
detection, eight broad range PCR assays were tested for their validity in the context of canine 
papillomaviruses (pages 42-48). The most suitable PCR assay was chosen to test samples of 
clinically healthy dogs for papillomavirus DNA. Finding more than 50% of the dogs PCR 
positive indicates a high prevalence of papillomaviruses among the dog population, although 
none of tested animals displayed any signs of clinical papillomatosis. Similar prevalences can 
be found in humans (Antonsson, 2000). It remains an open question whether these dogs do 
carry papillomaviruses or just their DNA superficially on their skin or suffer from subclinical 
infections. They may as well be protected by antibodies, however the seroprevalence against 
the most abundant CPV1 was in a very similar population determined to be only around 10% 
(Lange, 2008). While the attempt in this study was to choose and use primers with a broad 
range, establishing a sensitive PCR based assay to able to distinguish beetween the different 
CPVs without the need for sequencing could be a desirable alternative approach for the future. 
Thus the distribution of individual CPVs could be determined and infections with more than 
one CPV could be identified. Such an approach would greatly benefit from a large number of 
entirely sequences CPV genomes. Furthermore it might be very informative to test for 
antibodies directed against CPVs and for CPV DNA in parallel to correlate such findings and 
to possibly infer the relevance of CPV DNA on the dogs skin. In this context studies testing 
individual dogs repeatedly over a certain period of time would be most informative, and could 
greatly improve our knowledge about papillomavirus biology and epidemiology. 
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A major and challenging question that arises from all these results is what the underlying 
mechanisms of papillomavirus associated disorders are. As model systems for bovine and 
human papillomaviruses have in the past provided valuable insights, a similar approach was 
projected (Baker, 1987; Fehrmann, 2005). To have such a tool for studies about the biology of 
canine papillomavirus infections, dog keratinocyte cell lines containing CPV DNA were 
established (pages 49-65). As the cell lines have been shown to harbour the papillomavirus 
DNA over more than a hundred passages they seem to be suitable for various experimental 
approaches. These cell lines can for example be used to address questions about the effects of 
the papillomavirus DNA and their gene products on the host cells using quantitative PCR or 
microarray techniques. Several genes have already been identified, who are typically up or 
down regulated in case of papillomavirus infections in humans. Some of those, like p16INK4a 
have a high predictive value about the malignant potential of a papillomavirus infection 
(Grce, 2010). RAFT cultures can in this context be a precious tool as it is an experimental 
setting close to the natural environment of papillomaviruses. As the papillomavirus lifecycle 
is closely linked to that of the host cell in such a setting cell stages exist, that are absent in 
monolayer cultures. Thus the introduced CPV DNA may unveil its potential only in such a 
culture system. 
The cell lines make it also possible to test the effects of cofactors which are often involved in 
malignant papillomavirus lesions, at least to a certain extend (Howley, 2007). Putative 
cofactors like UV light and chemical carcinogens will be primary candidates to be tested in 
the newly developed system. All this promises new insights into the papillomavirus host 
interactions in dogs but also in general and can help to deal with the various types of 
papillomas more sophisticated in the future. The technique may furthermore be applied to 
generate similar cell lines for other papillomaviruses in species of interest. 
 
Our identification of novel papillomaviruses in distinct papillomatoses in horses goes in line 
with the hypotheses we were able to support in dogs and that had previously been suggested 
and supported in cattle (Campo, 1984; Hatama, 2008; Hatama 2009). We were able to link the 
known but etiologically poorly characterized penile papillomas and the aural plaques to 
papillomaviruses (Scott, 2003) (pages 67-73). These very distinct disorders seem to be 
associated with different papillomavirus types, and there is evidence that EcPV2 comes in at 
least two different variants. Also the three now known equine papillomaviruses represent 
three different phylogenetic genera. As in dogs the sequencing of further papillomavirus types  
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and also subtypes and variants is desirable to gain more understanding about the diseases and 
about papillomavirus evolution. Especially the surprising finding that there may be a kind of 
monophylogeny in equine papillomaviruses encourages the search for further 
papillomaviruses of horses as well as of other equide species to improve the resolution of the 
phylogenetic tree. 
 
In horses as well as in dogs the DNA of certain papillomaviruses can be identified on the 
clinically unaffected skin (Vanderstraeten, 2011). We therefore intended to locate the viral 
DNA in the relatively common EcPV2 associated lesions of the penis (pages 74-85). The 
correlation of the presence of viral DNA with typically virus associated cell alterations 
supports causal relation between lesion and virus and is further supported by independent 
results of similar studies (Scase, 2010). However looking for a correlation between viral 
particles, DNA and RNA in such lesions would be a desirable approach to assess causality in 
the future. Further experiments should also address questions about the distribution of the 
virus among the horse population using for example PCR and ELISA techniques in 
combination and also the role of the genetic variability of EcPV2 would be worth 
investigating in more detail. 
 
Taken together our studies on canine and equine papillomaviruses and papillomatoses have 
indicated several associations between viruses and disorders, supported previous hypotheses 
and established new methods. They therefore can be seen as unique parts of the 
papillomavirus puzzle. Many new questions have arisen and further studies are warranted for 
which the described ones have paved a way. 
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